Bariatric Surgery and Outcomes
Moving in Gastroenterology, Gut, New England Journal of Medicine, JAMA, Nature Medicine.
- Moved this week
- 0
Rebuilt
Moved this week
Nothing in this area has moved yet this week.
Latest in Bariatric Surgery and Outcomes
Newest first · last 60 days
Metabolic dysfunction-associated steatotic liver disease (MASLD) significantly increases colorectal cancer (CRC) risk, especially with greater disease severity and metabolic burden, according to expert consensus.
- 3 cites
Surgical and endoscopic therapies, including radiofrequency, plication, and mucosal resection, offer diverse options for treating GERD patients.
Effective obesity treatments, including new medications and procedures, are available but have not significantly reduced obesity rates in the US, which remain stable.
Once-weekly survodutide significantly reduces body weight by approximately 12-13% in adults with obesity without diabetes, outperforming placebo in a phase 3 trial.
- Open access
- 18 cites
Browse JClub
Journals this month
- bioRxiv5569
- medRxiv1746
- Environ Res485
- PNAS463
- Sci Adv439
- JAMA255
- Cell Rep210
- BMJ205
- Nat Commun177
- Environ Pollution170
- Lancet149
- Science138
- NEJM119
- Applied & Environ Microbio116
- Curr Biol116
- J Exp Bot115
- mBio109
- Nature104
Moving areas, week to 3 Oct 2026
- Single-cell and spatial transcriptomics10
- Artificial Intelligence in Healthcare and Education8
- CAR-T cell therapy research7
- Neuroinflammation and Neurodegeneration Mechanisms6
- Lung Cancer Treatments and Mutations5
- Diabetes Treatment and Management4
- Pancreatic and Hepatic Oncology Research4
- Photosynthetic Processes and Mechanisms4
- Genomics and Chromatin Dynamics4
- Gut microbiota and health4